Rutin ameliorates nitrergic and endothelial dysfunction on vessels and corpora cavernosa of diabetic animals
Copyright © 2023 Elsevier Ltd. All rights reserved..
Endothelial dysfunction is an early complication of diabetes and it is related to both micro- and macroangiopathies. In addition, >70% of diabetic patients develop autonomic neuropathies. Increased oxidative stress has a major role in the development of both nitrergic and endothelial dysfunction. The aim of this work is to evaluate whether rutin, a potent antioxidant, could ameliorate nitrergic and/or endothelial dysfunction in diabetic animals. Primary and secondary treatment protocols with rutin were investigated on rat aortic rings and the mesenteric arteriolar bed, and on rabbit aortic rings and corpora cavernosa (RbCC) from both euglycemic and alloxan-diabetic animals. Acetylcholine endothelium-dependent and sodium nitroprusside endothelium-independent relaxations were compared in tissues from euglycemic or diabetic animals. Electrical field stimulation (EFS)-induced relaxation was performed only in the RbCC. Endothelial-dependent relaxations were blunted by 40% in vessels and neuronal relaxation was blunted by 50% in RbCC taken from diabetic animals when compared to euglycemic animals. Pre-treatment with rutin restored both neuronal and endothelial dependent relaxations in diabetic animals towards the values achieved in control euglycemic tissues. Rutin was able to ameliorate both endothelial dysfunction and nitrergic neuropathy in animal experimental models. Rutin could be a lead compound in the primary or secondary preventive ancillary treatment of endothelial and nitrergic dysfunction in the course of diabetes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:161 |
|---|---|
| Enthalten in: |
Research in veterinary science - 161(2023) vom: 01. Aug., Seite 163-172 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
de Morais Campos, Rafael [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
169D1260KM |
|---|
| Anmerkungen: |
Date Completed 24.07.2023 Date Revised 02.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rvsc.2023.06.020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359077269 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359077269 | ||
| 003 | DE-627 | ||
| 005 | 20240108140721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rvsc.2023.06.020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1246.xml |
| 035 | |a (DE-627)NLM359077269 | ||
| 035 | |a (NLM)37406575 | ||
| 035 | |a (PII)S0034-5288(23)00187-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a de Morais Campos, Rafael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rutin ameliorates nitrergic and endothelial dysfunction on vessels and corpora cavernosa of diabetic animals |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.07.2023 | ||
| 500 | |a Date Revised 02.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Endothelial dysfunction is an early complication of diabetes and it is related to both micro- and macroangiopathies. In addition, >70% of diabetic patients develop autonomic neuropathies. Increased oxidative stress has a major role in the development of both nitrergic and endothelial dysfunction. The aim of this work is to evaluate whether rutin, a potent antioxidant, could ameliorate nitrergic and/or endothelial dysfunction in diabetic animals. Primary and secondary treatment protocols with rutin were investigated on rat aortic rings and the mesenteric arteriolar bed, and on rabbit aortic rings and corpora cavernosa (RbCC) from both euglycemic and alloxan-diabetic animals. Acetylcholine endothelium-dependent and sodium nitroprusside endothelium-independent relaxations were compared in tissues from euglycemic or diabetic animals. Electrical field stimulation (EFS)-induced relaxation was performed only in the RbCC. Endothelial-dependent relaxations were blunted by 40% in vessels and neuronal relaxation was blunted by 50% in RbCC taken from diabetic animals when compared to euglycemic animals. Pre-treatment with rutin restored both neuronal and endothelial dependent relaxations in diabetic animals towards the values achieved in control euglycemic tissues. Rutin was able to ameliorate both endothelial dysfunction and nitrergic neuropathy in animal experimental models. Rutin could be a lead compound in the primary or secondary preventive ancillary treatment of endothelial and nitrergic dysfunction in the course of diabetes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antioxidant | |
| 650 | 4 | |a Aortic rings | |
| 650 | 4 | |a Corpora cavernosa | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Nitric oxide | |
| 650 | 7 | |a Rutin |2 NLM | |
| 650 | 7 | |a 5G06TVY3R7 |2 NLM | |
| 650 | 7 | |a Nitroprusside |2 NLM | |
| 650 | 7 | |a 169D1260KM |2 NLM | |
| 650 | 7 | |a Acetylcholine |2 NLM | |
| 650 | 7 | |a N9YNS0M02X |2 NLM | |
| 650 | 7 | |a Nitric Oxide |2 NLM | |
| 650 | 7 | |a 31C4KY9ESH |2 NLM | |
| 700 | 1 | |a Lima, Lucília Maria Abreu Lessa Leite |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Ariana Gomes |e verfasserin |4 aut | |
| 700 | 1 | |a Santiago, Renata Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Paz, Iury Araújo |e verfasserin |4 aut | |
| 700 | 1 | |a Cabral, Pedro Henrique Bezerra |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Cláudia Ferreira |e verfasserin |4 aut | |
| 700 | 1 | |a Fonteles, Manassés Claudino |e verfasserin |4 aut | |
| 700 | 1 | |a do Nascimento, Nilberto Robson Falcão |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Research in veterinary science |d 1965 |g 161(2023) vom: 01. Aug., Seite 163-172 |w (DE-627)NLM000035211 |x 1532-2661 |7 nnns |
| 773 | 1 | 8 | |g volume:161 |g year:2023 |g day:01 |g month:08 |g pages:163-172 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rvsc.2023.06.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 161 |j 2023 |b 01 |c 08 |h 163-172 | ||